153 related articles for article (PubMed ID: 18006011)
1. Na,K-adenosine triphosphatase alpha1-subunit predicts survival of renal clear cell carcinoma.
Seligson DB; Rajasekaran SA; Yu H; Liu X; Eeva M; Tze S; Ball W; Horvath S; deKernion JB; Rajasekaran AK
J Urol; 2008 Jan; 179(1):338-45. PubMed ID: 18006011
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the Na,K-ATPase alpha- and beta-subunit expression profiles of bladder cancer using tissue microarrays.
Espineda C; Seligson DB; James Ball W; Rao J; Palotie A; Horvath S; Huang Y; Shi T; Rajasekaran AK
Cancer; 2003 Apr; 97(8):1859-68. PubMed ID: 12673711
[TBL] [Abstract][Full Text] [Related]
3. High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma.
Parker AS; Kosari F; Lohse CM; Houston Thompson R; Kwon ED; Murphy L; Riehle DL; Blute ML; Leibovich BC; Vasmatzis G; Cheville JC
Cancer; 2006 Jul; 107(1):37-45. PubMed ID: 16736510
[TBL] [Abstract][Full Text] [Related]
4. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival.
Miyata Y; Koga S; Kanda S; Nishikido M; Hayashi T; Kanetake H
Clin Cancer Res; 2003 May; 9(5):1741-9. PubMed ID: 12738729
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role.
Miyata Y; Iwata T; Maruta S; Kanda S; Nishikido M; Koga S; Kanetake H
Eur Urol; 2007 Sep; 52(3):791-7. PubMed ID: 17207914
[TBL] [Abstract][Full Text] [Related]
9. p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma.
Shvarts O; Seligson D; Lam J; Shi T; Horvath S; Figlin R; Belldegrun A; Pantuck AJ
J Urol; 2005 Mar; 173(3):725-8. PubMed ID: 15711252
[TBL] [Abstract][Full Text] [Related]
10. Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.
Kim HL; Seligson D; Liu X; Janzen N; Bui MH; Yu H; Shi T; Belldegrun AS; Horvath S; Figlin RA
J Urol; 2005 May; 173(5):1496-501. PubMed ID: 15821467
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein expression in renal cell carcinoma: subcellular localization and prognostic significance.
Tüzel E; Kirkali Z; Yörükoglu K; Mungan MU; Sade M
J Urol; 2001 May; 165(5):1710-3. PubMed ID: 11342961
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of vitamin D receptor and retinoid X receptor expression in renal cell carcinoma.
Obara W; Konda R; Akasaka S; Nakamura S; Sugawara A; Fujioka T
J Urol; 2007 Oct; 178(4 Pt 1):1497-503. PubMed ID: 17707062
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma.
Horiguchi A; Asano T; Asano T; Ito K; Sumitomo M; Hayakawa M
J Urol; 2008 Sep; 180(3):1137-40. PubMed ID: 18639282
[TBL] [Abstract][Full Text] [Related]
14. Proposal of an improved prognostic classification for pT3 renal cell carcinoma.
Terrone C; Gontero P; Volpe A; Porpiglia F; Bollito E; Zattoni F; Frea B; Tizzani A; Fontana D; Scarpa RM; Rossetti SR
J Urol; 2008 Jul; 180(1):72-8. PubMed ID: 18485380
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of beta-subunit of Na,K-ATPase in human clear-cell renal cell carcinoma.
Rajasekaran SA; Ball WJ; Bander NH; Liu H; Pardee JD; Rajasekaran AK
J Urol; 1999 Aug; 162(2):574-80. PubMed ID: 10411090
[TBL] [Abstract][Full Text] [Related]
16. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
[TBL] [Abstract][Full Text] [Related]
17. Expression of bone morphogenetic proteins, the subfamily of the transforming growth factor-beta superfamily, in renal cell carcinoma.
Kwak C; Park YH; Kim IY; Moon KC; Ku JH
J Urol; 2007 Sep; 178(3 Pt 1):1062-7. PubMed ID: 17644140
[TBL] [Abstract][Full Text] [Related]
18. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
Klatte T; Patard JJ; de Martino M; Bensalah K; Verhoest G; de la Taille A; Abbou CC; Allhoff EP; Carrieri G; Riggs SB; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Urol; 2008 May; 179(5):1719-26. PubMed ID: 18343437
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
[TBL] [Abstract][Full Text] [Related]
20. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index.
Santos Arrontes D; Fernández Aceñero MJ; García González JI; Martín Muñoz M; Paniagua Andrés P
J Urol; 2008 Mar; 179(3):857-61. PubMed ID: 18221956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]